Arcadia Biosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $1,302 | $1,455 | $1,200 | $1,216 |
Gross Profit | 418 | 631 | 518 | 389 |
EBITDA | 858 | -1,486 | -1,207 | -2,258 |
EBIT | 856 | -1,501 | -1,220 | -2,279 |
Net Income | 856 | -4,458 | 2,599 | -4,064 |
Net Change In Cash | 1,302 | 1,455 | 1,200 | 1,216 |
Free Cash Flow | -257 | -2,033 | -1,588 | -2,209 |
Cash | 1,120 | 1,376 | 3,159 | 4,242 |
Basic Shares | 1,371 | 1,367 | 1,366 | 1,363 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $5,045 | $4,454 | $7,418 | $6,780 |
Gross Profit | 2,082 | 2,280 | 1,317 | -1,928 |
EBITDA | -7,499 | -5,731 | -14,749 | -27,710 |
EBIT | -7,612 | -6,018 | -15,228 | -28,755 |
Net Income | -7,038 | -13,981 | -15,376 | -14,660 |
Net Change In Cash | 5,045 | 4,454 | 7,418 | 6,780 |
Free Cash Flow | -9,643 | -15,299 | -14,049 | -26,875 |
Cash | 4,242 | 6,518 | 20,644 | 28,685 |
Basic Shares | 1,363 | 1,236 | 599 | 532 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0.62 |
2025-06-30 | -$3.26 |
2025-03-31 | $1.90 |
2024-12-31 | -$2.99 |
